Polymorphisms in TP53, MDM2 Genes and Risk of Renal Cell Carcinoma in a Mongolian Population
Objective: Renal cell carcinoma (RCC) is one of the most common malignancies of the kidney, with genetic factors playing a critical role in its development. Among the key genetic factors, TP53 and MDM2 gene polymorphisms have been implicated in cancer susceptibility, but their association with RCC r...
Saved in:
| Main Authors: | Ganbayar Batmunkh, Munkhtuya Tumurkhuu, Myagmarsuren Purevsuren, Bayan-Undur Dagvadorj, Yerkyebulan Mukhtar, Tsogzolmaa Shiirevnyamba, Ganbolor Yura, Naranjargal Davaadorj, Shiirevnyamba Avirmed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mongolian National University of Medical Sciences
2025-03-01
|
| Series: | Central Asian Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://www.mongoliajol.info/index.php/CAJMS/article/view/4028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells
by: Sean F. Cooke, et al.
Published: (2025-09-01) -
MDM1 overexpression promotes p53 expression and cell apoptosis to enhance therapeutic sensitivity to chemoradiotherapy in patients with colorectal cancer
by: Ningxin Ren, et al.
Published: (2025-03-01) -
Dual EMCV-IRES-integrated dengue virus can express an exogenous gene and cellular Mdm2 integration suppresses the dengue viral replication
by: Tadahisa Teramoto
Published: (2025-01-01) -
Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus
by: A.H. AlBosale, et al.
Published: (2022-03-01) -
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
by: Ye Huang, et al.
Published: (2025-04-01)